Cytokines and peripheral analgesia

Advances in Experimental Medicine and Biology

Volumn 521, Issue , 2003, Pages 40-50

  Schäfer, Michael ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; OPIATE PEPTIDE; PROOPIOMELANOCORTIN; TUMOR NECROSIS FACTOR ALPHA;

ANALGESIA; BIOLOGICAL MODEL; CONCENTRATION RESPONSE; CORTICOTROPIN RELEASE; CYTOKINE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; NERVOUS SYSTEM; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW; SENSORY NERVE;

ANALGESIA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN-1; LEUKOCYTES; MICE; OPIOID PEPTIDES; PAIN; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, OPIOID;

EID: 0038410263     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (38)

1. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288(5472):1765-1769.
2. Dinarello CA, Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998; 16:457-499.
3. Mansour A, Fox CA, Burke et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 1994; 350: 412-38.
4. Schäfer M, Imai Y, Uhl GR et al. Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol 1995; 279:165-9.
5. Hassan AH, Ableitner A, Stein C et al. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 1993; 55:185-95.
6. Mousa SA, Zhang Q, Sitte N et al. beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 2001; 115(1-2):71-78.
7. Stein C, Machelska H, Binder W et al. Peripheral opioid analgesia. Curr Opin Pharmacol 2000, in press.
8. Cabot PJ, Carter L, Galddon C et al. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats, J Clin Invest 1997; 100:142-148.
9. Machelska H, Cabot PJ, Mousa SA et al. Pain control in inflammation governed by selectins [see comments], Nat Med 1998; 4:1425-8.
10. Wynn PC, Aguilera J, Morell et al. Properties and regulation of high-affinity pituitary receptors for corticotropin-releasing factor. Biochem Biophys Res Commun 1983; 110:602-605.
11. Chen R, Lewis KA, Perrin MH et al. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993; 90(19):8967-71.
12. Rivier C, Brownstein M, Spiess J et al. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin and corticosterone. Endocrinology 1982; 110:272-276.
13. Ban E, Milon G, Prudhomme N et al. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 1991; 43(1):21-30.
14. Cunningham ET Jr, Wada E, Carter DB et al. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci 1992; 3:1101-14.
15. Bernton EW, Beach JE, Holaday JW et al. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987; 238(4826):519-21.
16. Fagarasan MO, Eskay R, Axelrod J. Interleukin-1 potentiates the secretion of beta-endorphin induced by secretagogues in a mouse pituitary cell line (AtT-20). Proc Natl Acad Sci USA 1989; 86(6):2070-3.
17. Besedovsky HO, del Rey A, Klusman I et al. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol 1991; 40(4-6):613-8.
18. Perlstein RS, Whitnall MH, Abrams JS et al. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993;132(3):946-52.
19. Smith EM, Morrill AC, Meyer WJ et al. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins, Nature 1986; 321:881-882.
20. Kavelaars A, Ballieux RE and Heijnen CJ. The role of IL-1 in the corticotropin-releasing factor and arginine- vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells. J Immunol 1989; 142:2338-42.
21. Heijnen CJ, Kavelaars A, Ballieux RE. Beta-endorphin: cytokine and neuropeptide. Immunol Rev 1991; 119:41-63.
22. Cabot PJ, Carter L, Schäfer M et al. Methionine-enkephalin- and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 2001, in press.
23. Schäfer, M, Carter, L, Stein, C. Interleukin-1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue, Proc Natl Acad Sci USA 1994; 91:4219-23.
24. Meir A, Ginsburg S, Butkevich A et al. Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol Rev 1999; 79:1019-88.
25. De Souza EB, Perrin MH, Rivier J et al. Corticotropin-releasing factor receptors in rat pituitary gland: autoradiographic localization. Brain Res 1984; 296(1):202-7.
26. Schäfer M, Mousa SA and Stein C. Corticotropin-releasing factor in antinociception and inflammation, Eur J Pharmacol 1997, 323: 1-10.
27. Webster EL and De Souza EB. Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides. Endocrinology 1988; 122: 609-17.
28. Castro MG, Morrison E. Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit Rev Neurobiol 1997; 11(1):35-57.
29. Mousa, S.A., Schäfer, M., Mitchell, WM et al. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol 1996; 311:221-31.
30. Uhl J, Newton RC, Giri JG et al. Identification of IL-1 receptors on human monocytes, J Immunol 1989; 142:1576-81.
31. Radulovic M, Dautzenberg FM, Sydow S et al. Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells. J Immunol 1999; 162:3013-21.
32. McCarthy JR, Heinrichs SC, Grigoriadis DE. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharm Des 1999; 5(5):289-315.
33. Hargreaves KM, Dubner R, Costello AH. Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur J Pharmacol 1989, 170:275-9.
34. Ferreira SH, Lorenzetti BB, Bristow AF et al. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988; 334:698-700.
35. Stein C, Hassan AH, Przewlocki R et al. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990; 87:5935-9.
36. Stein C, Gramsch C and Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J Neurosci 1990; 10:1292-8.
37. Schäfer M, Mousa SA, Zhang Q et al. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA 1996; 93:6096-100.
38. Karalis K, Sano H, Redwine J et al. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991; 254:421-3.